Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Nantahala Capital Management, LLC's stake in Fulcrum Therapeutics, Inc. fell to 4.58% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Nantahala Capital Management, LLC's stake in Fulcrum Therapeutics, Inc. fell to 4.58%, 3,050,040 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.58%
- Shares
- 3,050,040
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 4.58% | 3,050,040 |
| Wilmot B. Harkey | 4.58% | 3,050,040 |
| Daniel Mack | 4.58% | 3,050,040 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026